EP 4392021 A1 20240703 - LIPOSOMES, COMPOSITIONS COMPRISING THE SAME, USES THEREOF
Title (en)
LIPOSOMES, COMPOSITIONS COMPRISING THE SAME, USES THEREOF
Title (de)
LIPOSOMEN, ZUSAMMENSETZUNGEN DAMIT, VERWENDUNGEN DAVON
Title (fr)
LIPOSOMES, COMPOSITIONS LES COMPRENANT, LEURS UTILISATIONS
Publication
Application
Priority
- IT 202100022253 A 20210824
- IB 2022057879 W 20220823
Abstract (en)
[origin: WO2023026179A1] Liposomes coated with hyaluronic acid having a molecular weight greater than 17000 Daltons, preferably between 20000 and 60000 Daltons. The liposomes may contain an active ingredient, such as, for example, a protein kinase enzyme inhibitor, preferably selected from imatinib, nintedanib and other derivatives belonging to the tyrosine kinase inhibitor class. The liposomes may be effectively used in the treatment, preferably by inhalation, of respiratory diseases.
IPC 8 full level
A61K 9/127 (2006.01); A61K 31/506 (2006.01); A61K 47/36 (2006.01); A61P 11/00 (2006.01)
CPC (source: EP)
A61K 9/0073 (2013.01); A61K 9/1271 (2013.01); A61K 9/1278 (2013.01); A61K 31/506 (2013.01); A61K 47/36 (2013.01); A61P 11/00 (2017.12)
Citation (search report)
See references of WO 2023026179A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2023026179 A1 20230302; EP 4392021 A1 20240703; IT 202100022253 A1 20230224
DOCDB simple family (application)
IB 2022057879 W 20220823; EP 22769372 A 20220823; IT 202100022253 A 20210824